Release of cholecystokinin from rat midbrain slices and modulatory effect of D2 DA receptor stimulation (Q41905017)

reason for preferred rank

13 October 2017

title

Release of cholecystokinin from rat midbrain slices and modulatory effect of D2 DA receptor stimulation (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

28 October 2022

Release of cholecystokinin from rat midbrain slices and modulatory effect of D2DA receptor stimulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

1 reference

3

S. I. Lentz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

author name string

A. S. Freeman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

L. A. Chiodo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

K. Wade

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

M. J. Bannon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682000

28 October 2022

publication date

1 August 1991

1 reference

13 October 2017

2 August 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682000

full work available at URL

28 October 2022

number of pages

7

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:000689939190353W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

https://api.elsevier.com/content/article/PII:000689939190353W?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

28 October 2022

1 reference

13 October 2017

volume

555

1 reference

13 October 2017

issue

2

1 reference

13 October 2017

page(s)

281-287

1 reference

Dopamine ?Autoreceptors?: Pharmacological characterization by microiontophoretic single cell recording studies

13 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin

28 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Mesolimbic dopaminergic neurones and somatodendritic mechanisms

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Kainic acid inhibits cholecystokinin release from rat hippocampal slices

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitro

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin octapeptide: Vesicular localization and calcium dependent release from rat brain in vitro

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin neuron systems and their interactions with the presynaptic features of the dopamine neuron systems. A morphometric and neurochemical analysis involving studies on the action of cholecystokinin-8 and cholecystokinin-58.

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Release of dopamine from dendrites in rat substantia nigra

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The regulation of cholecystokinin release from rat caudatoputamen in vitro

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Release of endogenous norepinephrine and dopamine from rat brain regions in vitro

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The localization and characterization of substance P and substance K in striatonigral neurons

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleus

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor

28 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Dopamine D1-receptor stimulation reduces neostriatal cholecystokinin release

28 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Dopamine modulates cholecystokinin release in neostriatum.

28 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Release of dopamine in vivo from cat substantia nigra

28 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum

28 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Amphetamine-induced release of dopamine from the substantia nigra in vitro

28 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices

28 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined byin situ hybridization

28 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions

28 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Forebrain projections from cholecystokininlike-immunoreactive neurons in the rat midbrain

28 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin

28 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry

28 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum

28 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Electrophysiologically identified nigral dopaminergic neurons intracellularly labeled with HRP: light-microscopic analysis

28 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Evidence that type A CCK receptors facilitate dopamine efflux in rat brain

28 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens

28 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin

28 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat.

28 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Does cholecystokinin potentiate dopamine action in the nucleus accumbens?

28 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons

28 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

28 October 2022

Identifiers

1 reference

13 October 2017

1 reference